IMMUNE PHARMACEUTICALS INC Business Finance Contracts & Agreements
106 Contracts & Agreements
- Assignment Agreements (1 contract)
- Debenture Agreements (5)
- Exchange Agreements (2)
- Investment Agreements (2)
- Loan Agreements (6)
- Note Agreements (13)
- Purchase Agreements (24)
- Registration Rights Agreements (3)
- Release Agreements (2)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (2)
- Warrant Agreements (35)
- Press release dated March 7, 2019 (Filed With SEC on March 8, 2019)
- Form of Investor Note (Filed With SEC on October 10, 2018)
- Form of Warrant (Filed With SEC on October 10, 2018)
- Form of Debenture (Filed With SEC on October 10, 2018)
- Securities Purchase Agreement, dated October 9, 2018 (Filed With SEC on October 10, 2018)
- Convertible Promissory Note, dated September 12, 2018, by and between Immune Pharmaceuticals, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 18, 2018)
- Securities Purchase Agreement, dated September 12, 2018, by and between Immune Pharmaceuticals, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 18, 2018)
- General Release of Claims, dated as of August 28, 2018, by and between Immune Pharmaceuticals Inc. and Elliot M. Maza (Filed With SEC on August 29, 2018)
- Form of Convertible Debenture (Filed With SEC on May 14, 2018)
- Securities Purchase Agreement (Filed With SEC on May 14, 2018)
- Form of Warrant (Filed With SEC on October 18, 2017)
- Form of Warrant Agency Agreement (Filed With SEC on October 16, 2017)
- Form of Warrant (Filed With SEC on October 16, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 16, 2017)
- Form of Warrant Agency Agreement (Filed With SEC on October 11, 2017)
- Form of Warrant (Filed With SEC on October 11, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 11, 2017)
- ORIGINALISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on August 24, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 24, 2017)
- SENIORSECURED CONVERTIBLEPROMISSORY NOTE DUEJuly 7, 2018 (Filed With SEC on July 10, 2017)
- EXCHANGE AGREEMENT (Filed With SEC on July 10, 2017)
- ASSIGNMENT AGREEMENT (Filed With SEC on July 10, 2017)
- ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on May 15, 2017)
- ORIGINALISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on May 10, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 10, 2017)
- COMMON STOCK PURCHASE WARRANT IMMUNEPHARMACEUTICALS, INC. (Filed With SEC on April 19, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 19, 2017)
- 6% CONVERTIBLE NOTE (Filed With SEC on April 19, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 19, 2017)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 22, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 22, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2016)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 7, 2016)
- COMMON STOCK PURCHASE WARRANT IMMUNEPHARMACEUTICALS inc. (Filed With SEC on August 3, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 3, 2016)
- PROMISSORY NOTE (Filed With SEC on July 19, 2016)
- STOCK PURCHASE AGREEMENT (Filed With SEC on July 29, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on July 29, 2015)
- LOANAND SECURITY AGREEMENT (Filed With SEC on July 29, 2015)
- WARRANTAGREEMENT To Purchase Shares of Common Stock of IMMUNE PHARMACEUTICALS INC. Dated as of July __, 2015 (the “EffectiveDate”) (Filed With SEC on July 29, 2015)
